Get the Stockscreener App
2.96
1.00%
-0.03
Pre-market:
2.94
-0.02
-0.68%
Onconetix Inc stock is traded at $2.96, with a volume of 37,261.
It is down -1.00% in the last 24 hours and down -3.27% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$2.99
Open:
$3.02
24h Volume:
37,261
Relative Volume:
0.34
Market Cap:
$4.60M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.0272
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
+27.04%
1M Performance:
-3.27%
6M Performance:
-52.62%
1Y Performance:
-94.62%
1-Day Range:
$2.9201
$3.15
1-Week Range:
$2.34
$3.15
52-Week Range:
$2.1001
$179.35
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
2.96 | 4.65M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Onconetix Inc Stock (ONCO) Latest News
Why pension funds invest in Onconetix Inc. (J4T) stockTrade Volume Report & AI Driven Stock Reports - Newser
Will Onconetix Inc. (J4T) stock enhance shareholder valuePortfolio Gains Report & Weekly Stock Performance Updates - Newser
What insider purchases suggest about Onconetix Inc. (J4T) stockJuly 2025 Trends & Safe Capital Growth Plans - Newser
Is Onconetix Inc. (J4T) stock worth holding before Fed meetingQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
Is Onconetix Inc. (J4T) stock resilient in recession scenarios2025 Price Momentum & Smart Money Movement Tracker - Newser
Can Onconetix Inc. (J4T) stock sustain margin levelsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Why Onconetix Inc. (J4T) stock signals breakout potential2025 Institutional Moves & Daily Growth Stock Tips - BỘ NỘI VỤ
Onconetix, Inc. (ONCO) -6.5% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
How Onconetix Inc. (J4T) stock expands through international marketsWeekly Trend Summary & Fast Gain Swing Alerts - moha.gov.vn
Is Onconetix Inc. (J4T) stock undervalued at current price2025 Top Gainers & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Total debt per share of Onconetix Inc – MUN:J4T - TradingView
Working capital per share of Onconetix Inc – MUN:J4T - TradingView
Is Onconetix Inc a good long term investmentSupport and Resistance Levels & Fast Growing Capital Growth - earlytimes.in
Oncopeptides announces the Nomination Committee - MarketScreener
Can you recover from losses in Onconetix Inc.2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Will Onconetix Inc. (J4T) stock announce special dividendSell Signal & Daily Growth Stock Investment Tips - newser.com
Will Onconetix Inc. (J4T) stock profit from fiscal stimulus2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Tools to assess Onconetix Inc.’s risk profileJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
What’s the recovery path for long term holders of Onconetix Inc.2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Will Onconetix Inc. (J4T) stock draw ESG focused fundsJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
Why analysts upgrade Onconetix Inc. stockJuly 2025 Summary & Trade Opportunity Analysis Reports - newser.com
Order flow analysis tools used on Onconetix Inc.Analyst Upgrade & Momentum Based Trading Signals - newser.com
What hedge fund activity signals for Onconetix Inc. stock2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
Can Onconetix Inc. (J4T) stock resist broad market declinesBuy Signal & Momentum Based Trading Ideas - newser.com
Is Onconetix Inc. stock reversal real or fakeJuly 2025 Opening Moves & Low Risk Entry Point Guides - newser.com
Real time social sentiment graph for Onconetix Inc.July 2025 Sentiment & Expert Curated Trade Ideas - newser.com
What catalysts could drive Onconetix Inc. stock higherWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Market reaction to Onconetix Inc.’s recent newsDividend Hike & Accurate Entry/Exit Alerts - newser.com
How Onconetix Inc. (J4T) stock trades after rate cutsQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
How to forecast Onconetix Inc. trends using time seriesMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com
Analyzing net buyer seller activity in Onconetix Inc.July 2025 EndofMonth & Trade Opportunity Analysis Reports - newser.com
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):